194 related articles for article (PubMed ID: 35508667)
1. Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hepatic steatosis.
Li Y; Talbot CL; Chandravanshi B; Ksiazek A; Sood A; Chowdhury KH; Maschek JA; Cox J; Babu AKS; Paz HA; Babu PVA; Meyerholz DK; Wankhade UD; Holland W; Shyong Tai E; Summers SA; Chaurasia B
Sci Rep; 2022 May; 12(1):7273. PubMed ID: 35508667
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance.
Ussher JR; Folmes CD; Keung W; Fillmore N; Jaswal JS; Cadete VJ; Beker DL; Lam VH; Zhang L; Lopaschuk GD
PLoS One; 2012; 7(5):e37703. PubMed ID: 22629445
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
Ussher JR; Koves TR; Cadete VJ; Zhang L; Jaswal JS; Swyrd SJ; Lopaschuk DG; Proctor SD; Keung W; Muoio DM; Lopaschuk GD
Diabetes; 2010 Oct; 59(10):2453-64. PubMed ID: 20522596
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats.
Campana M; Bellini L; Rouch C; Rachdi L; Coant N; Butin N; Bandet CL; Philippe E; Meneyrol K; Kassis N; Dairou J; Hajduch E; Colsch B; Magnan C; Le Stunff H
Mol Metab; 2018 Feb; 8():23-36. PubMed ID: 29233519
[TBL] [Abstract][Full Text] [Related]
5. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
[TBL] [Abstract][Full Text] [Related]
6. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome.
Yang G; Badeanlou L; Bielawski J; Roberts AJ; Hannun YA; Samad F
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E211-24. PubMed ID: 19435851
[TBL] [Abstract][Full Text] [Related]
7. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
8. Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.
Anhê FF; Varin TV; Le Barz M; Pilon G; Dudonné S; Trottier J; St-Pierre P; Harris CS; Lucas M; Lemire M; Dewailly É; Barbier O; Desjardins Y; Roy D; Marette A
Diabetologia; 2018 Apr; 61(4):919-931. PubMed ID: 29270816
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
10. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
[TBL] [Abstract][Full Text] [Related]
11. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
[TBL] [Abstract][Full Text] [Related]
12. Effects of serine palmitoyltransferase inhibition by myriocin in ad libitum-fed and nutrient-restricted ewes.
Davis AN; Myers WA; Eduardo Rico J; Feng Wang L; Chang C; Richards AT; Moniruzzaman M; Haughey NJ; McFadden JW
J Anim Sci; 2021 Aug; 99(8):. PubMed ID: 34324668
[TBL] [Abstract][Full Text] [Related]
13. Effects of a novel polyphenol-rich plant extract on body composition, inflammation, insulin sensitivity, and glucose homeostasis in obese mice.
van der Zande HJP; Lambooij JM; Chavanelle V; Zawistowska-Deniziak A; Otero Y; Otto F; Lantier L; McGuinness OP; Le Joubioux F; Giera M; Maugard T; Peltier SL; Sirvent P; Guigas B
Int J Obes (Lond); 2021 Sep; 45(9):2016-2027. PubMed ID: 34079069
[TBL] [Abstract][Full Text] [Related]
14. Ceramides mediate cigarette smoke-induced metabolic disruption in mice.
Thatcher MO; Tippetts TS; Nelson MB; Swensen AC; Winden DR; Hansen ME; Anderson MC; Johnson IE; Porter JP; Reynolds PR; Bikman BT
Am J Physiol Endocrinol Metab; 2014 Nov; 307(10):E919-27. PubMed ID: 25269485
[TBL] [Abstract][Full Text] [Related]
15. Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
Santos IB; de Bem GF; Cordeiro VSC; da Costa CA; de Carvalho LCRM; da Rocha APM; da Costa GF; Ognibene DT; de Moura RS; Resende AC
Nutr Res; 2017 Jul; 43():69-81. PubMed ID: 28739056
[TBL] [Abstract][Full Text] [Related]
16. Chardonnay Grape Seed Flour Ameliorates Hepatic Steatosis and Insulin Resistance via Altered Hepatic Gene Expression for Oxidative Stress, Inflammation, and Lipid and Ceramide Synthesis in Diet-Induced Obese Mice.
Seo KH; Bartley GE; Tam C; Kim HS; Kim DH; Chon JW; Kim H; Yokoyama W
PLoS One; 2016; 11(12):e0167680. PubMed ID: 27977712
[TBL] [Abstract][Full Text] [Related]
17. CTRP1 prevents high fat diet-induced obesity and improves glucose homeostasis in obese and STZ-induced diabetic mice.
Ren M; Pan J; Yu X; Chang K; Yuan X; Zhang C
J Transl Med; 2022 Oct; 20(1):449. PubMed ID: 36195912
[TBL] [Abstract][Full Text] [Related]
18. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
19. Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity.
Kalinovich A; Dehvari N; Åslund A; van Beek S; Halleskog C; Olsen J; Forsberg E; Zacharewicz E; Schaart G; Rinde M; Sandström A; Berlin R; Östenson CG; Hoeks J; Bengtsson T
Diabetologia; 2020 Aug; 63(8):1603-1615. PubMed ID: 32472192
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.
Fillmore N; Keung W; Kelly SE; Proctor SD; Lopaschuk GD; Ussher JR
Exp Physiol; 2015 Jun; 100(6):730-41. PubMed ID: 25786668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
